Biomarkers in Bone Disease
There are many conditions that affect the skeletal system. On a worldwide basis, osteoarthritis alone affects 10%-15 percent of those over 60 years of age and in some countries more than 30-50% of postmenopausal women will have osteopenia or osteoporosis. With the increasing ageing population, maint...
| Συγγραφή απο Οργανισμό/Αρχή: | |
|---|---|
| Άλλοι συγγραφείς: | , |
| Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
| Γλώσσα: | English |
| Έκδοση: |
Dordrecht :
Springer Netherlands : Imprint: Springer,
2017.
|
| Σειρά: | Biomarkers in Disease: Methods, Discoveries and Applications,
|
| Θέματα: | |
| Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Serum uric acid and biomarkers of lumbar spine bone mineral density
- Use of alkaline phosphatase (ALP) activity and disease severity to determine secular changes in bone disease as applied to Paget's disease of the bone
- Bone Turnover and Spinal Cord Injury
- Bone-related proteins as markers in vascular remodelling
- Serum Sclerostin as Biomarker in Osteogenesis Imperfecta
- Parathyroid Hormone (PTH) assays and applications to bone disease: Overview on methodology
- Registered microcomputed tomography data as a four dimensional imaging biomarker of bone formation and resorption
- Use of bone biomarkers after weight loss: Example of bariatric surgery
- Adiponectin as biomarker of osteoporosis
- Effect of statins on bone turnover markers
- Chitinases as biomarkers in bone studies
- Hormone relaxin as biomarker for bone health and disease
- Panoramic radiomorphometric indices of mandible: Biomarker for osteoporosis
- Hip Fracture Risk is Strongly Related to Circulating Levels of the Advanced Glycation End-product Carboxy-Methyl Lysine (CML)
- Effects of glucose on bone markers: Overview of current knowledge with focus on diabetes, glucose, and bone markers
- Traditional medicine and use of bone biomarkers
- Osteosarcoma Biomarkers discovery using "omics" approaches
- Creatine kinase as biomarker in osteogenesis imperfecta
- Ameloblastin as biomarker of bone
- Biomarker genes in autosomal dominant osteopetrosis type II (ADO II)
- Bone markers in Rett syndrome
- Bone Specific Alkaline Phosphatase and Exercise
- Bone turnover markers and glucocorticoid treatments
- Overview of biochemical markers of bone metabolism
- Biomarkers of natural radionuclides in bone and teeth
- Bone markers throughout sexual development: epidemiological significance and population-based findings
- Parathyroid hormone (PTH) and the relationship between PTH and bone health: structure, physiology, actions, and ethnicity
- Quantitative ultrasound as a biomarker tool in newborn infants for bone
- Bone biomarkers in gestational hypertension
- Bone biomarkers in intrauterine growth restriction
- Raman spectroscopy as a biomarker-investigative tool in bone metabolism
- Pentosidine as a biomarker for poor bone quality and elevated fracture risk
- Spine bone texture and the trabecular bone score (TBS)
- Bone biomarkers in HIV
- Bone Biomarkers Related to Osteoarthritis
- Dietary Soy Phytoestrogens and Biomarkers of Osteoporosis
- Utilisation and reference values of osteocalcin and procollagen type 1 n-propeptide
- Analysis of integrin alpha2beta1 (a2b1) expression as a biomarker of skeletal metastasis
- Circulating Sclerostin in Bone Sclerosing Disorders
- Pentraxin 3 as a bone biomarker
- Sirtuins as markers of bone disease: a focus on osteoarthritis and osteoporosis
- Tartarate resistant acid phosphatase as a biomarker of bone remodeling. .
